Role of the extracellular signal-regulated kinase 1/2 signaling pathway in the process of thrombin-promoting airway remodeling in ovalbumin-allergic rats. (February 2015)
- Record Type:
- Journal Article
- Title:
- Role of the extracellular signal-regulated kinase 1/2 signaling pathway in the process of thrombin-promoting airway remodeling in ovalbumin-allergic rats. (February 2015)
- Main Title:
- Role of the extracellular signal-regulated kinase 1/2 signaling pathway in the process of thrombin-promoting airway remodeling in ovalbumin-allergic rats
- Authors:
- Bi, Meirong
Guo, Aili
Zhao, Hongyang
Sun, Xuewu
Chen, Qiang
Yu, Li
Shi, Wei
Wang, Yan
Shen, Guohong
Wang, Xueying
Zhao, Yingchun
Zhang, Nan
Xu, Mi
Qin, Mingming
Zhu, Weiwei - Abstract:
- <abstract> <title>Abstract</title> <p> <italic>Context</italic>: Although it is recognized that thrombin plays a key role in airway remodeling during chronic asthma. In a previous study, we have proved that thrombin promotes airway remodeling via PAR-1 in OVA-allergic rats, but little is known about intracellular signaling pathway involved in the event.</p> <p> <italic>Objective</italic>: In this study, we intend to explore the impact of pERK1/2 signaling pathway on the process of thrombin-induced airway remodeling in OVA-allergic rats.</p> <p> <italic>Materials and methods</italic>: A rat model of chronic asthma was set up by systemic sensitization and repeated challenge to OVA. The doses of thrombin, recombinant hirudin, PAR-1 inhibitor ER-112780-06, and pERK1/2 inhibitor PD98059 varied for different groups. The expression of pERK1/2 was analyzed by western blot and RT-PCR. Secretion of TGF-β1 and IL-6 was detected by ELISA.</p> <p> <italic>Results</italic>: The expression of pERK1/2 was higher in the airway of asthmatic rats than those of normal rats, and was significantly increased by thrombin treatment but decreased by thrombin-inhibitor treatment. Airway remodeling was enhanced by thrombin but weakened by pERK1/2 inhibitor. Expression of growth factors and IL-6 in asthmatic rats was significantly increased by thrombin treatment and decreased by thrombin-inhibitor treatment and pERK1/2 inhibitor treatment.</p> <p> <italic>Conclusion</italic>: These results suggest that<abstract> <title>Abstract</title> <p> <italic>Context</italic>: Although it is recognized that thrombin plays a key role in airway remodeling during chronic asthma. In a previous study, we have proved that thrombin promotes airway remodeling via PAR-1 in OVA-allergic rats, but little is known about intracellular signaling pathway involved in the event.</p> <p> <italic>Objective</italic>: In this study, we intend to explore the impact of pERK1/2 signaling pathway on the process of thrombin-induced airway remodeling in OVA-allergic rats.</p> <p> <italic>Materials and methods</italic>: A rat model of chronic asthma was set up by systemic sensitization and repeated challenge to OVA. The doses of thrombin, recombinant hirudin, PAR-1 inhibitor ER-112780-06, and pERK1/2 inhibitor PD98059 varied for different groups. The expression of pERK1/2 was analyzed by western blot and RT-PCR. Secretion of TGF-β1 and IL-6 was detected by ELISA.</p> <p> <italic>Results</italic>: The expression of pERK1/2 was higher in the airway of asthmatic rats than those of normal rats, and was significantly increased by thrombin treatment but decreased by thrombin-inhibitor treatment. Airway remodeling was enhanced by thrombin but weakened by pERK1/2 inhibitor. Expression of growth factors and IL-6 in asthmatic rats was significantly increased by thrombin treatment and decreased by thrombin-inhibitor treatment and pERK1/2 inhibitor treatment.</p> <p> <italic>Conclusion</italic>: These results suggest that ERK1/2 signaling pathway may play an important role in the process of thrombin-promoting airway remodeling in OVA-allergic rats, and pERK1/2 inhibitor effectively inhibits the process.</p> </abstract> … (more)
- Is Part Of:
- Immunopharmacology and immunotoxicology. Volume 37:Number 1(2015:Feb.)
- Journal:
- Immunopharmacology and immunotoxicology
- Issue:
- Volume 37:Number 1(2015:Feb.)
- Issue Display:
- Volume 37, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 37
- Issue:
- 1
- Issue Sort Value:
- 2015-0037-0001-0000
- Page Start:
- 26
- Page End:
- 34
- Publication Date:
- 2015-02
- Subjects:
- Immunopharmacology -- Periodicals
Immunotoxicology -- Periodicals
Antibody-toxin conjugates -- Periodicals
Immunology -- Periodicals
615.37 - Journal URLs:
- http://informahealthcare.com/journal/ipi ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/08923973.2014.993083 ↗
- Languages:
- English
- ISSNs:
- 0892-3973
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4369.760200
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4218.xml